IGF-I and IGF-II in relation to colorectal cancer

International Journal of Cancer

Volumn 83, Issue 1, 1999, Pages 15-17

  Manousos, Orestis ^a   Souglakos, John ^a   Bosetti, Cristina ^b,c   Tzonou, Anastasia ^a   Chatzidakis, Vassilia ^d   Trichopoulos, Dimitrios ^b   Adami, Hans Olov ^b,e   Mantzoros, Christos ^d,f  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HARVARD CENTER FOR CANCER PREVENTION   (United States)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d HARVARD MEDICAL SCHOOL   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT;

AGED; BODY HEIGHT; BODY WEIGHT; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; RECTAL NEOPLASMS; RISK FACTORS;

EID: 0032819589     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO;2-Y     Document Type: Article

References (21)

1. BOLKE, K., CRAMER, D.W., TRICHOPOULOS, D. and MANTZOROS, C., Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology, 9, 570-573 (1998).
2. BOSTICK, R.M., POTTER, J.D., KUSHI, L.H., SELLERS, T.A., STEINMETZ, K.A., MCKENZIE, D.R., GAPSTUR, S.M. and FOLSOM, A.R., Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women. Cancer Causes Control, 5, 38-52 (1994).
3. BRUNING, P.F., VAN DOORN, J., BONFER, J.M., VAN NOORD, P.A., KORSE, C.M., LINDERS, T.C. and HAR, A.A., Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int. J. Cancer, 62, 266-270 (1995).
4. CHAN, J.M., STAMPFER, M.J., GIOVANUCCI, E., GANN, P.H., MA, J., WILKINSON, P., HENNEKENS, C.H. and POLLAK, M., Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 279, 563-566 (1998).
5. EL ATIQ, F., Garrouste, F., Remacle-Bonnet, M., Sastre, B., Pommier, G., Alterations in serum levels of insulin-like growth factors and insulin-like growth-factor-binding proteins in patients with colorectal cancer. Int. J. Cancer, 57, 491-497 (1994).
6. KAWAMOTO, K., ONODERA, H., KONDO, S., KAN, S., IKEUCHI, D., MAETANI, S. and IMAMURA, M., Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients', correlation with tumor progression, proliferative activity and survival. Oncology, 55, 242-248 (1998).
7. LE ROITH, D., CLEMMONS, D., NISSLEY, P. and RECHLER, M.M., NIH conference. Insulin-like growth factors in health and disease. Ann. Intern. Med., 116, 854-862 (1992).
8. MANTZOROS, C.S. and FLIER, J.S., Insulin resistance: the clinical spectrum. Adv. Endocrinol. Metab., 6, 193-232 (1995).
9. MANTZOROS, C.S., TZONOU, A., SIGNORELLO, L.B., STAMPFER, M., TRICHOPOULOS, D. and ADAMI, H.-O., Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Brit. J. Cancer, 76, 1115-1118 (1997).
10. MCKEOWN-EYSSEN, G., Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol. Biomarkers Prevent., 3, 687-695 (1994).
11. ORME, S.M., MCNALLY, R.J.Q., CARTWRIGHT, R.A. and BELTCHETZ, P.E., Mortality and cancer incidence in acromegaly: retrospective cohort study. J. clin. Endocrinol. Metab., 83, 2730-2734 (1998).
12. PETRIDOU, E., DESSYPRIS, N., SPANOS, E., MANTZOROS, C., SKALKIDOU, A., KALMANTI, M., KOLIOUSKAS, D., KOSMIDIS, H., PANAGIOTOU, J.P., PIPEROPOULOU, F., TZORTZATOU, F. and TRICHOPOULOS, D., Insulin-like growth factor-1 and binding protein-3 in relation to childhood leukemia. Int. J. Cancer, 80, 494-496 (1999).
13. SINGH, P., DAI, B., YALLAMPALLI, C., LU, X. and SCHROY, P., Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II. Endocrinology, 137, 1764-1774 (1996).
14. SINGH, P., DAI, B., YALLAMPALLI, C. and XU, Z., Expression of IGF-II and IGF-binding proteins by colon cancer cells in relation to growth response to IGFs. Amer. J. Physiol., 267, G608-G617 (1994).
15. SINGH, P. and RUBIN, N., Insulin like growth factors and binding proteins in colon cancer. Gastroenterology, 105, 1218-1237 (1993).
16. TRAN, T.T., MEDLINE, A. and BRUCE, W.R., Insulin promotion of colon tumors in rats. Cancer Epidemiol. Biomarkers Prevent., 5, 1013-1015 (1996)
17. TRICOLI, J.V., RALL, L.B., KARAKOUSIS, C.P., HERRERA, L., PETZELL, N.J., BELL, J.I. and SHOWS, T.B., Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res., 46, 6169-6173 (1986).
18. TRITOS, N.A. and MANTZOROS, C.S., Syndromes of severe insulin resistance. J. clin. Endocrinol. Metab., 83, 3025-3030 (1998).
19. WEIDERPASS, E., GRIDLEY, G., EKBOM, A., NYREN, O., HJALGRIM, A. and ADAMI, H.-O., Diabetes mellitus and risk of large bowel cancer. J. nat. Cancer Inst., 89, 660-661 (1997).
20. WOLK, A., MANTZOROS, C.S., ANDERSON, S.O., BERGSTROM, R., SIGNORELLO, L.P., LAGIOU, P., TRICHOPOULOS, D. and ADAMI, H.-O., Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J. nat. Cancer Inst., 90, 911-915 (1998).
21. ZARRILLI, R., PIGNATA, S., ROMANO, M., GRAVINA, A., CASOLA, S., BRUNI, C.B. and ACQUAVIVA, A.M., Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. Cell Growth Differentiation, 5, 1085-1091 (1994).